Indication
t(11;14)(q13;q32)
1 clinical trial
1 product
1 drug
Clinical trial
An Open Label, Phase II Investigator Initiated Study of Venetoclax and Acalabrutinib in Previously Treated Relapsed/Refractory Patients With Mantle Cell Lymphoma (MCL)Status: Active (not recruiting), Estimated PCD: 2026-02-08
Drug
VarlilumabProduct
Venetoclax